Filing Details

Accession Number:
0001209191-12-034026
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-06-15 14:23:46
Reporting Period:
2012-06-14
Filing Date:
2012-06-15
Accepted Time:
2012-06-15 14:23:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1388195 Pharmerica Corp PMC Retail-Drug Stores And Proprietary Stores (5912) 870792558
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1194422 S Gregory Weishar 1901 Campus Place
Louisville KY 40299
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.01 Par Value Acquisiton 2012-06-14 31,000 $9.48 592,392 No 4 P Direct
Common Stock, $0.01 Par Value Acquisiton 2012-06-14 4,000 $9.37 7,000 No 4 P Indirect By Spouse
Common Stock, $0.01 Par Value Acquisiton 2012-06-14 500 $9.36 1,500 No 4 P Indirect By Son
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect By Spouse
No 4 P Indirect By Son
Footnotes
  1. Represents the weighted average purchase price for the transactions reported on this line. The range of prices for the transactions reported on this line was $9.37 to $9.50. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.
  2. Represents the weighted average purchase price for the transactions reported on this line. The range of prices for the transactions reported on this line was $9.36 to $9.369. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.
  3. Represents the weighted average purchase price for the transactions reported on this line. The range of prices for the transactions reported on this line was $9.358 to $9.359. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.